Drug class
Peripheral dopamine D2-receptor antagonist; antiemetic and prokinetic
Mechanism of action
Blocks peripheral dopamine D2 receptors in the chemoreceptor trigger zone and gastrointestinal tract, producing antiemetic effects and increasing upper gastrointestinal motility.
General use cases
- Relief of symptoms of nausea and vomiting; use, dose and duration are restricted by product information and jurisdiction-specific cardiac safety precautions
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
